Just for record keeping purposes... Carol's was added yesterday at... You know when the give you five decimals they are sort of laughing at you... Sorry...meant to update you earlier this morning...$6.9871. Lets just say $7.00!
Naaaa.... watching Chewy. Hey that Goldman Sachs thing about oil hitting $65.... hmph, they must think Biden is gonna win. I can't see it going that high with all the capacity in the Permian. That's certainly an interesting call. There's a lot one could read into that, from many angles.
Lots of really deep thought today Van. I think an argument is starting to form that there is a second form of re opening stock you could call it cyclical that now comes into play. Gyms, Movies, Fast food, etc. On the Virus front... Van if you like to double your gummy-- try on our little stem cell play for Covid.-- Once Again you would be in cheaper than me on my idea! Athersys CEO 'confident' drug will deliver in COVID-19, Spectrum News 1 reports 11:54 ATHX Athersys has focused on creating a stem cell therapy for people suffering from ARDS, the leading cause of death among COVID-19 infection patients, and CEO Gil Van Bokkelen is confident that the company's patented MultiStem therapy will deliver in COVID, Spectrum News 1's Micaela Marshall reports. In May, University Hospitals became the first site for a "MultiStem Administration for COVID-19 Induced Acute Respiratory Distress Syndrome" clinical trial, and Van Bokkelen says "It's been going well. I mean, UH is very active. We got a number of things that are going on that basically give us a lot of hope for this."
Lets Save The World Everyone-!-- ATHX-- The company’s patented therapy is called “MultiStem.” Van Bokkelen says recent clinical trial results showed that a single dose of MultiStem rapidly improved lung function, reduced mortality, lowered the amount of days spent in the ICU on a ventilator, and increased patients’ functional independence after leaving the hospital. “All of those things basically gave us a lot of confidence that MultiStem, in this properly conducted randomized double-blind placebo-controlled trial, was providing real evidence that we could help patients that right now their only intervention is to put them on a ventilator, and that was pretty exciting, and actually led to our third fast track designation from the FDA,” said Van Bokkelen. Van Bokkelen is not surprised many people are dying from COVID-19 induced ARDS. “We kind of anticipated when we saw the news about this new coronavirus and the patients were becoming seriously and critically ill, that it might actually result in a lot of patients that were developing ARDS, and sure enough, that’s exactly what’s happened. Unfortunately, where we’ve seen now millions of patients around the world that have actually become diagnosed with Acute Respiratory Distress Syndrome. It’s been very problematic,” he said. Athersys hopes to help fix the problem.
Tailwind Stocks-- Near Tech stocks-- The theory at gummybearadvisors is that certain stocks have a Tailwind due to Covid that is not going away. Now pure tech stocks that have orders pulled forwards I am not talking about, Cloud, email secure all of that. But if more people are out of work and more people are trying to develop side action to build up income then it's safe to say Ebay is doing better. If stores are closing in retail they are opening on Ebay. Used cars are very very hot right now- Ebay is a play on that with their Ebay motors. If my wife is any example she went back to Ebay after years away.. and bought her way through Covid by buying pretty vases to put flowers in. Is Ebay a tech stock? I would say No. And of course Yes. My wife is bombarded by reminders that she looked at something and that buyer now is willing to go lower because that buyer was told about her snooping.. it's all very clever and unfortunately for me facilitates a lot of deals/ Ebay should go to $90- This same theory I am applying to Go Daddy. More people are going to try and do their own thing. They have to.~stoney
Special 2nd Update** specialty chemicals and materials maker. -- What if I told you a company had higher sales in China not lower. -- What if I told you that same company is going to change the world with their ' warm asphalt ' Ok What is China 6 you ask? What's Going in NGVT’s Favor? The company is gaining from higher sales in China as automakers in the country have essentially completed the implementation of the China 6 standard. It saw higher demand for its automotive activated carbon products in China in the second quarter of 2020 on the back of the China 6 implementation. The momentum is expected to continue in the third quarter. Ingevity is also taking certain cost-reduction measures in the wake of the coronavirus pandemic to boost profitability. These actions include reduction of headcount through an early retirement program, streamlining of manufacturing processes and reduction of traveling expenses and plant spending. Ingevity saw benefits of these initiatives in the second quarter. The company expects these actions to deliver $35 million of savings this year. Moreover, Ingevity is seeing healthy growth in pavement technologies on strength in North America. It is seeing continued adoption of the Evotherm warm-mix technology.<--!! Lowers Co2. The company is also benefiting from the acquisition of the Capa caprolactone business. Capa has a strong and market-leading business that focuses on high-growth end-use applications. The buyout enabled Ingevity with a new technology platform to drive revenue and earnings growth." Ingevity Corporation Price and Consensus- gummybearPT- $85 Ingevity Corporation Price and Consensus
TWO SIDES OF EVERY STORY-- Getting TMO to produce if that lures Giv $'s from Project Warped... well then it's a good move... But lets muddy the waters a bit-- Inovio press release looks like 'stock promotion,' Muddy Waters says 09:23 INO Carson Block's Muddy Waters tweeted, "$INO - this looks exactly like what a stock promotion would do - i.e., price declines so put out a press release about a LOI. Why else does this lack substance? Two reasons. 1 Still no tech transfer from VGXI, so unknown whether they can even make it. 2. A big problem $INO had w/ VGXI was that INO needed about $2 bln to pay for the ~100 mm doses. Is Thermo Fisher going to produce FOR FREE? How much would INO need to pre-pay?" I have to look into that tech transfer VGXI part...
One thing I've learned Stoney, the most important thing when it comes to winning with stocks is patience my friend. Before the bell I wrote Chewy would go down. Out of the gate it ran to the high of the day. Like $61 and change in the first few minutes. It was a head fake, and tbh, a younger me would have fell for it. A lot of folks did, it was over 1.5 MM shares in the first 15 minutes +/-. Near term stocks are a game, I could write for the next hour on how its played and the mechanics behind it.Thing is Stoney, the big money has shopping lists... there's certain stocks. Chewy is one. On the surface as these things go, its overpriced af, but look at its chart, and look at the whole Peter Lynch thing you yourself observed. I don't even have to do a channel check, everyone I friggin know uses them for their pets. Their margins are low to be sure, but looking ahead, there exists a plethora of value added revenue generators for this stock. Its just getting started. The selloff today was (as I pointed out before the bell)... a shake-out of the weak hands. The drop at the EOD... that was just daytraders getting out. Make no mistake Stoney... this stock is one for granny, or better yet her grandkids. As long as funny money is the rule of the day, this bitch is heading north. I hope it drops 15% Monday. I'll buy this bitch all day long around $49... just like I said before the bell.